Does AZD-1222 Cause Pulmonary embolism? 189 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 189 reports of Pulmonary embolism have been filed in association with AZD-1222. This represents 8.1% of all adverse event reports for AZD-1222.
189
Reports of Pulmonary embolism with AZD-1222
8.1%
of all AZD-1222 reports
5
Deaths
59
Hospitalizations
How Dangerous Is Pulmonary embolism From AZD-1222?
Of the 189 reports, 5 (2.6%) resulted in death, 59 (31.2%) required hospitalization, and 27 (14.3%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZD-1222. However, 189 reports have been filed with the FAERS database.
What Other Side Effects Does AZD-1222 Cause?
Headache (838)
Fatigue (784)
Pyrexia (735)
Pain (579)
Covid-19 (515)
Arthralgia (508)
Nausea (494)
Palpitations (485)
Dyspnoea (472)
Abdominal discomfort (467)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which AZD-1222 Alternatives Have Lower Pulmonary embolism Risk?
AZD-1222 vs AZELAIC ACID
AZD-1222 vs AZELASTINE
AZD-1222 vs AZELASTINE\FLUTICASONE
AZD-1222 vs AZELNIDIPINE
AZD-1222 vs AZILECT